Alzamend Neuro Stock Price Prediction

ALZN Stock  USD 0.68  0.01  1.45%   
As of today, the RSI of Alzamend Neuro's share price is approaching 41. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Alzamend Neuro, making its price go up or down.

Oversold Vs Overbought

41

 
Oversold
 
Overbought
Alzamend Neuro stock price prediction is an act of determining the future value of Alzamend Neuro shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Alzamend Neuro's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Alzamend Neuro and does not consider all of the tangible or intangible factors available from Alzamend Neuro's fundamental data. We analyze noise-free headlines and recent hype associated with Alzamend Neuro, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Alzamend Neuro's stock price prediction:
EPS Estimate Current Year
(1.45)
EPS Estimate Next Year
(1.44)
Wall Street Target Price
21
EPS Estimate Current Quarter
(0.32)
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Alzamend Neuro based on different types of headlines from major news networks to social media. The Alzamend stock price prediction module provides an analysis of price elasticity to changes in media outlook on Alzamend Neuro over a specific investment horizon. Using Alzamend Neuro hype-based prediction, you can estimate the value of Alzamend Neuro from the perspective of Alzamend Neuro response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Alzamend Neuro using Alzamend Neuro's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Alzamend using crowd psychology based on the activity and movement of Alzamend Neuro's stock price.

Alzamend Neuro Implied Volatility

    
  0.0  
Alzamend Neuro's implied volatility exposes the market's sentiment of Alzamend Neuro stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Alzamend Neuro's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Alzamend Neuro stock will not fluctuate a lot when Alzamend Neuro's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Alzamend Neuro. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Alzamend Neuro to buy its stock at a price that has no basis in reality. In that case, they are not buying Alzamend because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Alzamend Neuro after-hype prediction price

    
  USD 0.66  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alzamend Neuro's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.081.516.76
Details
2 Analysts
Consensus
LowTargetHigh
3.644.004.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.43-0.36-0.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alzamend Neuro. Your research has to be compared to or analyzed against Alzamend Neuro's peers to derive any actionable benefits. When done correctly, Alzamend Neuro's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alzamend Neuro.

Alzamend Neuro After-Hype Price Prediction Density Analysis

As far as predicting the price of Alzamend Neuro at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alzamend Neuro or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alzamend Neuro, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Alzamend Neuro Estimiated After-Hype Price Volatility

In the context of predicting Alzamend Neuro's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alzamend Neuro's historical news coverage. Alzamend Neuro's after-hype downside and upside margins for the prediction period are 0.03 and 5.91, respectively. We have considered Alzamend Neuro's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.68
0.66
After-hype Price
5.91
Upside
Alzamend Neuro is dangerous at this time. Analysis and calculation of next after-hype price of Alzamend Neuro is based on 3 months time horizon.

Alzamend Neuro Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Alzamend Neuro is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alzamend Neuro backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alzamend Neuro, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.29 
5.25
  0.02 
  0.41 
6 Events / Month
11 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.68
0.66
2.94 
6,562  
Notes

Alzamend Neuro Hype Timeline

Alzamend Neuro is presently traded for 0.68. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.41. Alzamend is forecasted to decline in value after the next headline, with the price expected to drop to 0.66. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.94%, whereas the daily expected return is presently at -0.29%. The volatility of related hype on Alzamend Neuro is about 367.48%, with the expected price after the next announcement by competition of 1.09. About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.82. Alzamend Neuro had not issued any dividends in recent years. The entity had 1:15 split on the 31st of October 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days.
Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.

Alzamend Neuro Related Hype Analysis

Having access to credible news sources related to Alzamend Neuro's direct competition is more important than ever and may enhance your ability to predict Alzamend Neuro's future price movements. Getting to know how Alzamend Neuro's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alzamend Neuro may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TCONTRACON Pharmaceuticals 8.73 9 per month 12.11  0.02  19.59 (23.73) 108.97 
SLDBSolid Biosciences LLC(1.03)9 per month 4.42  0.05  9.65 (6.82) 26.59 
KZRKezar Life Sciences(0.03)8 per month 0.00 (0.05) 7.61 (5.81) 19.42 
SNTISenti Biosciences(0.01)2 per month 0.00 (0.14) 7.50 (8.70) 26.47 
XFORX4 Pharmaceuticals 0.28 8 per month 4.09  0.12  10.47 (7.00) 37.52 
INZYInozyme PharmaInc(0.35)8 per month 4.48  0.04  8.83 (8.42) 25.32 
TERNTerns Pharmaceuticals(0.09)7 per month 0.00 (0.05) 8.64 (8.38) 27.76 
DAWNDay One Biopharmaceuticals(0.57)9 per month 3.29  0.05  5.49 (4.70) 20.03 
HOOKHookipa Pharma(0.04)8 per month 3.14  0.03  6.25 (6.17) 24.40 
ABOSAcumen Pharmaceuticals(0.31)9 per month 0.00 (0.04) 7.28 (6.35) 23.58 
VECTVectivBio Holding AG 0.06 7 per month 0.88  0.20  5.61 (3.08) 39.30 
MOLNMolecular Partners AG(0.28)4 per month 0.00 (0.10) 4.90 (6.52) 23.10 
ADVMAdverum Biotechnologies 15.52 10 per month 5.75  0.09  15.08 (7.88) 64.40 
ALECAlector(0.43)8 per month 0.00 (0.14) 5.96 (8.23) 16.43 
ADAGAdagene(0.02)5 per month 0.00 (0.05) 10.16 (13.14) 32.26 

Alzamend Neuro Additional Predictive Modules

Most predictive techniques to examine Alzamend price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alzamend using various technical indicators. When you analyze Alzamend charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Alzamend Neuro Predictive Indicators

The successful prediction of Alzamend Neuro stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alzamend Neuro, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alzamend Neuro based on analysis of Alzamend Neuro hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alzamend Neuro's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alzamend Neuro's related companies.
 2021 2022 2024 (projected)
Current Ratio12.372.033.32
Net Debt To EBITDA1.140.350.3

Story Coverage note for Alzamend Neuro

The number of cover stories for Alzamend Neuro depends on current market conditions and Alzamend Neuro's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alzamend Neuro is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alzamend Neuro's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Alzamend Neuro Short Properties

Alzamend Neuro's future price predictability will typically decrease when Alzamend Neuro's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alzamend Neuro often depends not only on the future outlook of the potential Alzamend Neuro's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alzamend Neuro's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding6.5 M
Cash And Short Term Investments5.1 M
When determining whether Alzamend Neuro offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alzamend Neuro's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alzamend Neuro Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alzamend Neuro Stock:
Check out Alzamend Neuro Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Alzamend Stock, please use our How to Invest in Alzamend Neuro guide.
Note that the Alzamend Neuro information on this page should be used as a complementary analysis to other Alzamend Neuro's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Alzamend Stock analysis

When running Alzamend Neuro's price analysis, check to measure Alzamend Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alzamend Neuro is operating at the current time. Most of Alzamend Neuro's value examination focuses on studying past and present price action to predict the probability of Alzamend Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alzamend Neuro's price. Additionally, you may evaluate how the addition of Alzamend Neuro to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Is Alzamend Neuro's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alzamend Neuro. If investors know Alzamend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alzamend Neuro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Return On Assets
(1.67)
Return On Equity
(11.96)
The market value of Alzamend Neuro is measured differently than its book value, which is the value of Alzamend that is recorded on the company's balance sheet. Investors also form their own opinion of Alzamend Neuro's value that differs from its market value or its book value, called intrinsic value, which is Alzamend Neuro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alzamend Neuro's market value can be influenced by many factors that don't directly affect Alzamend Neuro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alzamend Neuro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alzamend Neuro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alzamend Neuro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.